Sapient Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Buy
885
+91
+11% +$43.7K 0.01% 281
2026
Q1
$391K Sell
794
-1,214
-60% -$659K 0.01% 310
2025
Q4
$1.17M Buy
2,008
+712
+55% +$403K 0.02% 190
2025
Q3
$599K Sell
1,296
-352
-21% -$164K 0.01% 243
2025
Q2
$669K Sell
1,648
-32
-2% -$13.4K 0.01% 225
2025
Q1
$837K Sell
1,680
-35
-2% -$19K 0.02% 204
2024
Q4
$893K Buy
1,715
+453
+36% +$249K 0.02% 193
2024
Q3
$781K Sell
1,262
-6
-0.5% -$3.55K 0.02% 213
2024
Q2
$702K Buy
1,268
+14
+1% +$8.02K 0.01% 201
2024
Q1
$729K Sell
1,254
-26
-2% -$14.6K 0.02% 206
2023
Q4
$680K Buy
+1,280
New +$620K 0.02% 207

Other funds holding TMO

Sapient Capital's TMO Position: Q2 2026 in Review

Sapient Capital increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $43.7K and bringing the position to 885 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #281.

Sapient Capital first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sapient Capital held 885 shares of Thermo Fisher Scientific worth $444K as of Q2 2026.
  • Sapient Capital bought 91 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.7K.
  • Thermo Fisher Scientific made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #281 holding.
  • Sapient Capital first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Thermo Fisher Scientific position peaked at $1.17M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.